J.W. Cole Advisors, Inc. Astrazeneca PLC Transaction History
J.W. Cole Advisors, Inc.
- $2.09 Billion
- Q2 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 5,554 shares of AZN stock, worth $435,322. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,554
Previous 6,172
10.01%
Holding current value
$435,322
Previous $418,000
3.59%
% of portfolio
0.02%
Previous 0.02%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,332Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.09 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.34 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.18 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.88 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $243B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...